Diagnostics Pipeline: Cizzle Bio Introduces Test for Earlier Lung Cancer Detection
The CIZ1B biomarker blood-based assay has 95% sensitivity for detecting earliest stage of the cancer
Already a member? Log in here
Emerging Tests-dtet
Diagnostics Pipeline: Xella Health Launches Platform Focused on Women’s Medical Issues
The startup is trying to close the care gap between female and male patients
Already a member? Log in here
Growing Need for Companion Diagnostics is Evident at Drug Discovery Event
The momentum for targeted therapies has downstream implications for clinical laboratories
Already a member? Log in here
Genetic Predisposition to Stress Fractures ID’d in Healthy Individuals
...
Already a member? Log in here
Methylation Patterns Are New Target for ctDNA Analysis
...
Already a member? Log in here
Disposable, Electrochemical Sensor IDs Wound Infections in Seconds
...
Already a member? Log in here
Inflammatory Markers May Diagnose Back Conditions
...
Already a member? Log in here
NGS-Based Test for CF Promises Faster, Cheaper, More Thorough Analysis
...
Already a member? Log in here
More Than 1/4 of FDA’s 2015 Drug Approvals for Targeted Therapies
From – Diagnostic Testing & Emerging Technologies
More than 28 percent of the novel new drugs approved by U.S. Food and Drug Administration (FDA) in 2015 were…
Already a member? Log in here
New Molecular Test for Cystic Fibrosis Promises Faster, Better, Cheaper Analysis
From – Diagnostic Testing & Emerging Technologies
The future of cystic fibrosis (CF) diagnosis is in sight. Testing for the genetic disease helped to fuel the first wave of clinical molecular diagnostics, and now an assay developed by…
Already a member? Log in here
Paper-Based Test May Increase Male Fertility Self-Testing
...
Already a member? Log in here
Cost Effectiveness of Nail Fungus Confirmatory Test Treatment-Specific
...
Already a member? Log in here